Dr. Iain Page is a Consultant in Infectious Diseases & General Medicine at the Western General Hospital in Edinburgh. He has a sub-specialist interest in Fungal Infections and in particular Chronic Pulmonary Aspergillosis (CPA) and is establishing a clinical service for CPA patients in collaboration with respiratory physician colleagues. He is also engaged in COVID-19 research and is the Principal Investigator for the Valneva COVID vaccine trial and an Investigator for the Oxford vaccine trial and RECOVERY therapeutics trials in Edinburgh.
He completed medical school and junior doctor training in Edinburgh. From 2007 he combined specialist training in Infectious Diseases in Manchester with several years of teaching and leading research projects in Malawi and Uganda. He completed his PhD in Chronic Pulmonary Aspergillosis in 2015 and was subsequently an Academic Clinical Lecturer at the UK National Aspergillosis Centre in Manchester, before returning to Edinburgh in 2020. He is secretary of CPANet, the European clinical network for CPA research.